Panse N, Gerk P
AAPS J. 2025; 27(2):65.
PMID: 40087222
DOI: 10.1208/s12248-025-01044-7.
Sanders H, Atkinson K, Smith B
Supramol Chem. 2025; 34(11-12):484-490.
PMID: 40046405
PMC: 11882149.
DOI: 10.1080/10610278.2024.2388731.
Knippenberg N, Bauwens M, Florea A, Rudi S, Schijns O, Hoogland G
ACS Chem Neurosci. 2025; 16(4):711-722.
PMID: 39878351
PMC: 11843609.
DOI: 10.1021/acschemneuro.4c00782.
Sun C, Liu B, Zhou F, Zheng Q, Dai C, Wei W
Molecules. 2023; 28(15).
PMID: 37570604
PMC: 10420250.
DOI: 10.3390/molecules28155634.
Kim H, Lee S, Sung S, Kim E, Jang I, Chung J
Drug Des Devel Ther. 2023; 17:1203-1210.
PMID: 37113469
PMC: 10128151.
DOI: 10.2147/DDDT.S404182.
Designed switch from covalent to non-covalent inhibitors of carboxylesterase Notum activity.
Atkinson B, Willis N, Zhao Y, Patel C, Frew S, Costelloe K
Eur J Med Chem. 2023; 251:115132.
PMID: 36934521
PMC: 10626578.
DOI: 10.1016/j.ejmech.2023.115132.
Pharmacokinetics of Long-Acting Aqueous Nano-/Microsuspensions After Intramuscular Administration in Different Animal Species and Humans-a Review.
Nguyen V, Darville N, Vermeulen A
AAPS J. 2022; 25(1):4.
PMID: 36456852
DOI: 10.1208/s12248-022-00771-5.
Mouse Pharmacokinetics and In Vitro Metabolism of SH-11037 and SH-11008, Synthetic Homoisoflavonoids for Retinal Neovascularization.
Kim E, Lee B, Kwon S, Corson T, Seo S, Lee K
Pharmaceutics. 2022; 14(11).
PMID: 36365089
PMC: 9697349.
DOI: 10.3390/pharmaceutics14112270.
Interspecies differences in stability kinetics and plasma esterases involved in hydrolytic activation of curcumin diethyl disuccinate, a prodrug of curcumin.
Ratnatilaka Na Bhuket P, Jithavech P, Ongpipattanakul B, Rojsitthisak P
RSC Adv. 2022; 9(8):4626-4634.
PMID: 35520191
PMC: 9060607.
DOI: 10.1039/c8ra08594c.
Ethyl pyruvate, a versatile protector in inflammation and autoimmunity.
Koprivica I, Djedovic N, Stojanovic I, Miljkovic D
Inflamm Res. 2022; 71(2):169-182.
PMID: 34999919
PMC: 8742706.
DOI: 10.1007/s00011-021-01529-z.
Efficacy of Novel Aminooxyacetic Acid Prodrugs in Colon Cancer Models: Towards Clinical Translation of the Cystathionine β-Synthase Inhibition Concept.
Hellmich M, Chao C, Modis K, Ding Y, Zatarain J, Thanki K
Biomolecules. 2021; 11(8).
PMID: 34439739
PMC: 8394431.
DOI: 10.3390/biom11081073.
Aryl -[ω-(6-Fluoroindol-1-yl)alkyl]carbamates as Inhibitors of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and Butyrylcholinesterase: Structure-Activity Relationships and Hydrolytic Stability.
Rudolph S, Dahlhaus H, Hanekamp W, Albers C, Barth M, Michels G
ACS Omega. 2021; 6(20):13466-13483.
PMID: 34056494
PMC: 8158844.
DOI: 10.1021/acsomega.1c01699.
Metabolism and Interspecies Variation of IMMH-010, a Programmed Cell Death Ligand 1 Inhibitor Prodrug.
Wang Y, Liu X, Zou X, Wang S, Luo L, Liu Y
Pharmaceutics. 2021; 13(5).
PMID: 33919384
PMC: 8143347.
DOI: 10.3390/pharmaceutics13050598.
Physiologically based kinetic modelling based prediction of in vivo rat and human acetylcholinesterase (AChE) inhibition upon exposure to diazinon.
Zhao S, Wesseling S, Spenkelink B, Rietjens I
Arch Toxicol. 2021; 95(5):1573-1593.
PMID: 33715020
PMC: 8113213.
DOI: 10.1007/s00204-021-03015-1.
Prediction of dose-dependent in vivo acetylcholinesterase inhibition by profenofos in rats and humans using physiologically based kinetic (PBK) modeling-facilitated reverse dosimetry.
Omwenga I, Zhao S, Kanja L, Mol H, Rietjens I, Louisse J
Arch Toxicol. 2021; 95(4):1287-1301.
PMID: 33651127
PMC: 8032624.
DOI: 10.1007/s00204-021-03004-4.
Synthesis, Anticancer Activity, and Preliminary Pharmacokinetic Evaluation of 4,4-Disubstituted Curcuminoid 2,2-bis(Hydroxymethyl)Propionate Derivatives.
Lee D, Hou Y, Yang J, Lin H, Chang T, Lee K
Molecules. 2020; 25(3).
PMID: 31979200
PMC: 7037731.
DOI: 10.3390/molecules25030479.
Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virus.
Good S, Moussa A, Zhou X, Pietropaolo K, Sommadossi J
PLoS One. 2020; 15(1):e0227104.
PMID: 31914458
PMC: 6949113.
DOI: 10.1371/journal.pone.0227104.
Reaction rate of pyruvate and hydrogen peroxide: assessing antioxidant capacity of pyruvate under biological conditions.
Guarino V, Oldham W, Loscalzo J, Zhang Y
Sci Rep. 2019; 9(1):19568.
PMID: 31862934
PMC: 6925109.
DOI: 10.1038/s41598-019-55951-9.
Targeting Histone Deacetylases in Myeloid Cells Inhibits Their Maturation and Inflammatory Function With Limited Effects on Atherosclerosis.
Luque-Martin R, Van den Bossche J, Furze R, Neele A, van der Velden S, Gijbels M
Front Pharmacol. 2019; 10:1242.
PMID: 31736752
PMC: 6830127.
DOI: 10.3389/fphar.2019.01242.
Creation of a long-acting rilpivirine prodrug nanoformulation.
Hilaire J, Bade A, Sillman B, Gautam N, Herskovitz J, Shetty B
J Control Release. 2019; 311-312:201-211.
PMID: 31491432
PMC: 6875695.
DOI: 10.1016/j.jconrel.2019.09.001.